(888) 645-1617

This episode's guest

E. Scott Sills, MD, PhD
E. Scott Sills, MD, PhD
Expert Contributor

Dr. E. Scott Sills of the Center for Advanced Genetics in Carlsbad, Ca. joins me on this episode of Drugwatch Radio. On this episode, we discuss the controversial medical device, Essure.

Since 1998, Dr. Sills has helped parents grow their families. Recently, however, he found himself using his expertise to remove Essure devices from women who suffered a wide array of complications from the device. Using a specialized, targeted surgical technique, Dr. Sills is able to remove the metal coils of Essure while sparing the uterus and cervix, avoiding a hysterectomy.

The Essure Permanent Birth Control System consists of two metal coils and is a type of permanent sterilization. A healthcare practitioner implants each coil in the woman’s fallopian tubes. After about 90 days, scar tissue builds up in the fallopian tubes, blocking the path of sperm to the egg and preventing pregnancy.

In his practice, Dr. Sills has seen women with Essure suffering from complications such as severe pelvic pain to perforated bowels and fractured devices in the fallopian tubes. An Essure Facebook support group called Essure problems has more than 30,000 members. Many claim the device ruined their lives.

Part of the reason the device is problematic is the lack of studies. Many of Dr. Sills’ patients have actually found themselves in clinical studies of successful Essure removals. On this show, he discusses the problems with the device, and how he helps women regain their quality of life.

Related Articles

More

The Legacy of Essure and Its Complications

Women may choose Essure as an option for permanent birth control but it requires more research on long-term side effects.

Learn More

Women Injured by Essure Birth Control Outraged by FDA Guidelines

The FDA's Essure recommendations include a black-box warning and patient checklist, but it is not enough for women injured by the device.

Learn More

FDA Approves Bayer’s Essure Study after Adverse Events, Deaths

FDA approves Bayer's Essure Permanent Birth Control postmarket study to collect data on safety risks.

Learn More

Sign Up for Drugwatch Podcast & Newsletter Alerts

Stay up to date on the latest podcast and drug and device news from Drugwatch.

    Thank You!

    You will now receive updates from Drugwatch.

    Free Essure Case Review